Use of modified oligo-beta-(1,3)-glucanes for treating diseases of the immune system, oligo-beta- (1,3v-glucane-(1,3)- mannose, oligo-beta-(1,3)-glucane-(1,3)- mannitol and derivatives thereof, methods for preparing the same and drugs containing them

摘要

The present invention relates to the use of at least one compound of the formula (I) or (II), in which Ri is H and n is an integer from 2 to 10, in the preparation of a drug for treating diseases from the group comprising tumour, cancer, viral disease, bacterial disease, fungal disease, immune system disease, auto-immune disease or disease associated with a Pimmunostimulation deficiency in human beings and warm-blood animals. The invention also relates to new products having a mannose or mannitol termination as well as a method for preparing the same.